Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Anticoagulant Effects of Different Doses of Nafamostat in CRRT in the ICU
NCT07469072Phase 2Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Nafabelltan in extracorporeal circuit thrombosis, sponsored by Southern Medical University Zhujiang Hospital. Started Apr 2026; status: recruiting.
02
Drugs
Nafabelltan
03
Conditions
extracorporeal circuit thrombosis
Beyond the preview
Go deeper on NCT07469072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07469072.